share_log

T2 Biosystems | SC 13G: Statement of acquisition of beneficial ownership by individuals-JACOB SAFIER(5.7%),JSAF HOLDINGS, LLC(5.7%)

T2 Biosystems | SC 13G: Statement of acquisition of beneficial ownership by individuals-JACOB SAFIER(5.7%),JSAF HOLDINGS, LLC(5.7%)

T2 Biosystems | SC 13G：超過5%持股股東披露文件-JACOB SAFIER(5.7%),JSAF HOLDINGS, LLC(5.7%)
美股SEC公告 ·  11/07 10:07

牛牛AI助理已提取核心訊息

On October 30, 2024, a significant filing was made with the United States Securities and Exchange Commission by JSAF Holdings, LLC and Jacob Safier, indicating a substantial investment in T2 Biosystems, Inc. The Schedule 13G filing, dated November 6, 2024, reveals that JSAF Holdings and Jacob Safier, as the portfolio manager, collectively own 1,000,000 shares of T2 Biosystems' common stock, which represents 5.7% of the company based on the number of shares reported as outstanding in T2 Biosystems' latest quarterly report. The filing specifies that this ownership stake is not intended for the purpose of changing or influencing the control of T2 Biosystems, nor is it connected with any transaction with such purpose or effect. The address for both JSAF Holdings and Jacob Safier is listed as The Wolfson Group, One State Street Plaza, New York, NY. The filing emphasizes that the information provided is accurate to the best of the signatories' knowledge after reasonable inquiry.
On October 30, 2024, a significant filing was made with the United States Securities and Exchange Commission by JSAF Holdings, LLC and Jacob Safier, indicating a substantial investment in T2 Biosystems, Inc. The Schedule 13G filing, dated November 6, 2024, reveals that JSAF Holdings and Jacob Safier, as the portfolio manager, collectively own 1,000,000 shares of T2 Biosystems' common stock, which represents 5.7% of the company based on the number of shares reported as outstanding in T2 Biosystems' latest quarterly report. The filing specifies that this ownership stake is not intended for the purpose of changing or influencing the control of T2 Biosystems, nor is it connected with any transaction with such purpose or effect. The address for both JSAF Holdings and Jacob Safier is listed as The Wolfson Group, One State Street Plaza, New York, NY. The filing emphasizes that the information provided is accurate to the best of the signatories' knowledge after reasonable inquiry.
2024年10月30日，美國證券交易委員會收到JSAF Holdings, LLC和Jacob Safier提交的重要申報，顯示他們對t2 biosystems公司進行了大規模投資。截至2024年11月6日的13G表格顯示，作爲投資組合經理，JSAF Holdings和Jacob Safier共同擁有t2 biosystems公司100萬股普通股，佔據公司總股本的5.7%，這一數據基於t2 biosystems公司最新季度報告中所報告的普通股數。申報指明，此持股不打算用於改變或影響t2 biosystems公司的控制，也不涉及具有這種目的或效果的任何交易。JSAF Holdings和Jacob Safier的地址均顯示爲紐約州紐約市State Street Plaza的The Wolfson Group。申報強調，提供的信息是簽署者在合理調查後所知的最準確信息。
2024年10月30日，美國證券交易委員會收到JSAF Holdings, LLC和Jacob Safier提交的重要申報，顯示他們對t2 biosystems公司進行了大規模投資。截至2024年11月6日的13G表格顯示，作爲投資組合經理，JSAF Holdings和Jacob Safier共同擁有t2 biosystems公司100萬股普通股，佔據公司總股本的5.7%，這一數據基於t2 biosystems公司最新季度報告中所報告的普通股數。申報指明，此持股不打算用於改變或影響t2 biosystems公司的控制，也不涉及具有這種目的或效果的任何交易。JSAF Holdings和Jacob Safier的地址均顯示爲紐約州紐約市State Street Plaza的The Wolfson Group。申報強調，提供的信息是簽署者在合理調查後所知的最準確信息。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間